bromochloroacetic-acid and Mixed-Tumor--Mesodermal

bromochloroacetic-acid has been researched along with Mixed-Tumor--Mesodermal* in 1 studies

Other Studies

1 other study(ies) available for bromochloroacetic-acid and Mixed-Tumor--Mesodermal

Article	Year
Simultaneous bilateral occurrence of a mixed mesodermal tumor and cystadenocarcinoma in the ovary. Pathology oncology research : POR, 2004, Volume: 10, Issue:2 The mixed mesodermal tumor is a very uncommon malignancy. The aggressiveness of this lesion is illustrated by extremely poor prospects for afflicted patients: postoperative survival is usually shorter than 24 months. According to the literature, malignant mixed tumor of the ovary is rather rare and its occurrence with other malignancy is exceptional. We report here a case of a 62-years old woman with serous cystadenocarcinoma in the right ovary and a heterologous malignant mixed mesodermal tumor in the left one. Both tumors expressed cytokeratins, while only the mesodermal tumor expressed S-100 and focal NSE. Topics: Biomarkers, Tumor; Cystadenocarcinoma, Serous; Female; Humans; Keratins; Middle Aged; Mixed Tumor, Mesodermal; Neoplasms, Second Primary; Ovarian Neoplasms; Phosphopyruvate Hydratase; S100 Proteins	2004

Article

Year

Simultaneous bilateral occurrence of a mixed mesodermal tumor and cystadenocarcinoma in the ovary.

Pathology oncology research : POR, 2004, Volume: 10, Issue:2

The mixed mesodermal tumor is a very uncommon malignancy. The aggressiveness of this lesion is illustrated by extremely poor prospects for afflicted patients: postoperative survival is usually shorter than 24 months. According to the literature, malignant mixed tumor of the ovary is rather rare and its occurrence with other malignancy is exceptional. We report here a case of a 62-years old woman with serous cystadenocarcinoma in the right ovary and a heterologous malignant mixed mesodermal tumor in the left one. Both tumors expressed cytokeratins, while only the mesodermal tumor expressed S-100 and focal NSE.

Topics: Biomarkers, Tumor; Cystadenocarcinoma, Serous; Female; Humans; Keratins; Middle Aged; Mixed Tumor, Mesodermal; Neoplasms, Second Primary; Ovarian Neoplasms; Phosphopyruvate Hydratase; S100 Proteins

2004